Trials / Completed
CompletedNCT01329042
Efficacy of Potassium Sodium Hydrogen Citrate Therapy on Renal Stone Recurrence and/or Residual Fragments After Shockwave Lithotripsy and Percutaneous Nephrolithotomy in Calcium Oxalate Urolithiasis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Ouiheng International Healthcare Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Extracorporeal shock wave lithotripsy (ESWL) and Percutaneous nephrolithotomy (PCNL) become the therapy of choice for renal stone. Although providing good results, stone recurrence is usually found as the therapies do not change the underlying metabolic abnormality. Among the metabolic disorders, hypocitraturia is an important risk factor for calcium nephrolithiasis. This study evaluate the preventive effects of potassium sodium citrate on stone recurrence as well as stone growth post ESWL or PCNL, in patients with calcium-containing stones.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Potassium-sodium citrate | The treated group was given oral potassium-sodium citrate 81 mEq/day The control group received no treatment |
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2007-10-01
- Completion
- 2008-02-01
- First posted
- 2011-04-05
- Last updated
- 2011-04-05
Source: ClinicalTrials.gov record NCT01329042. Inclusion in this directory is not an endorsement.